一种在现场治愈,剪切响应的生物材料,旨在对微血管的持久栓塞进行设计
Quynh P Pham1, Jeffrey V Groom1, Chander Sadasivan2
1Arsenal Medical, Inc, 100 Beaver Street, Suite 302, Waltham, MA, 02453, USA.
Advanced healthcare materials
|March 11, 2025
概括
新型生物材料NeoCast通过内血管栓塞提供优质的微血管封闭. 这种无溶剂的药物实现了持续的远部透和持久的阻塞,优于目前的栓塞剂.
科学领域:
- 生物材料科学 生物材料科学
- 干预性放射学 干预性放射学
- 血管外科 血管外科
背景情况:
- 血管内栓塞旨在使用栓塞剂封闭病态血管.
- 当前的药物在远距离透,反流和可用性方面存在局限性.
- 实现微血管封闭对于有效的脱细胞化至关重要.
研究的目的:
- 为了评估NeoCast,一种新的液体栓塞剂,其栓塞性能.
- 为了比较NeoCast的微血管封闭能力与现有的药物.
- 评估NeoCast的安全性,包括炎症和神经毒性.
主要方法:
- NeoCast是一种基于聚二甲基西洛的生物材料,在临床前的动脉和静脉模型中进行了测试.
- 使用标准微导管进行了带有和没有流量停止的栓塞.
- 性能根据远距离透,遮耐用性,光镜可见性和生物相容性进行评估.
主要成果:
- 尼奥卡斯特证明了可复制和优越的微血管的远端透.
- 该药物提供了持久的遮,具有出色的光镜可见性.
- 观察到轻度炎症,在脑组织植入时没有神经毒性的证据.
结论:
- NeoCast是一种下一代液体栓塞剂,旨在增强微血管封闭.
- 它的剪切反应性质和无溶剂成分解决了当前栓塞剂的局限性.
- 对于需要精确,远端栓塞的应用,NeoCast显示出显著的前景.
相关概念视频
01:16Vascular Spasm
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.